CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop targeted therapies for newly diagnosed Type 1 Diabetes Mellitus (T1DM) that minimize immune system interference, focusing on protecting and restoring beta-cells. It explores interventions involving immune cell re-education and novel therapies to promote tolerance and improve patient outcome…
This proposal will pioneer the concept of tailored interventions with minimal immune system interference in new onset T1DM, leading to beta-cell protection and restoration, based on a solid understanding of the disease pathogenesis.
This will enable experimental findings to be adopted for future clinical application.
Four work packages are grouped around ‘Reversal of autoimmunity’, in which two key players of the immune system in beta-cell destruction will be targeted: the dendritic cell (WP1:
R…
KATHOLIEKE UNIVERSITEIT LEUVEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Frankfurt Am Main
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Bristol
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Portugal, Lisboa
Type: Research institute
Activity type: Research Organisations
SME: No
Italy, Siena
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
